BioSpace News Archive

Alloy Therapeutics, Inc., a biotechnology ecosystem company and Wheeler Bio, Inc., an agile contract development and manufacturing organization, announced the formation of a non-exclusive, preferred service offering to drive translation from Discovery to CMC development and clinical material supply for ecosystem partners.

Alfasigma S.p.A. announced that it has, through its wholly owned subsidiary Interstellar Acquisition Inc., successfully completed its tender offer to purchase all outstanding shares of common stock of Intercept Pharmaceuticals, Inc., at a price of USD 19.00 per share, net to the seller thereof in cash, without interest, less any applicable withholding of taxes.

bit.bio, the company coding human cells for novel cures, announced its cell therapy pipeline and declared its lead cell therapy candidate as it prepares to enter clinical development in 2025.

Join the largest in-person gathering of CEOs from the worldwide Rejuvenation & Longevity biotech sector

Genetic information collected from seemingly healthy tissue near lung tumors may be a better predictor of whether cancer will come back after treatment than analysis of the tumors themselves, according to new research led by NYU Langone Health and its Perlmutter Cancer Center.

Cerevel Therapeutics announced that members of the management team will participate in two upcoming investor conferences during the month of November.

Oculis Holding AG, a global biopharmaceutical company purposefully driven to save sight and improve eye care, announced that Riad Sherif, MD, Chief Executive Officer, and Sylvia Cheung, Chief Financial Officer will be attending and presenting at the following upcoming investor conferences.

IMA203 data with focus on melanoma patients presented at the International Congress of the Society for Melanoma Research , November 8

Atea Pharmaceuticals, Inc. announced that members of the Atea management team will participate in and present a business update at the following investor conferences in November.

Bio-Path Holdings, Inc. announced that it will host a live conference call and audio webcast on Wednesday, November 15, 2023 at 8:30 a.m. ET to report financial results for the third quarter ended September 30, 2023 and to provide a business overview.